NCT02748798 Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders Status TERMINATED Phase EARLY_PHASE1
NCT02747381 The Effect of Vitamin D Supplementation on the Pulmonary Functions of Adult Asthmatic Egyptian Patients Status COMPLETED Phase PHASE4
NCT02745899 The Effect of Cow Milk Consumption on Respiratory Symptoms and Pulmonary Functions in Asthmatic and Non Asthmatic Children Status UNKNOWN Phase NA
NCT02743663 The Development of Novel Clinical Tests to Diagnose and Monitor Asthma in Preschool Children Status COMPLETED Phase N/A
NCT02742597 Patient-Centred Innovations for Persons With Multimorbidity - Ontario Status COMPLETED Phase NA
NCT02741271 Study of Efficacy and Long-Term Safety of Mometasone Furoate in Combination With Formoterol Fumarate Versus Mometasone Furoate in Children (5 to 11 Years of Age) With Persistent Asthma (MK-0887A-087) Status COMPLETED Phase PHASE3
NCT02740868 Xenon-129 and Inert Fluorinated Gas Lung MRI: Study of Healthy Volunteers and Participants With Pulmonary Disease Status RECRUITING Phase PHASE2
NCT02740049 In Vitro Evaluation of a Novel Drug on Airway Epithelial Cells Obtained From Participants With Severe Asthma Status COMPLETED Phase EARLY_PHASE1
NCT02735174 Improving Asthma Care by Partnering With School Nurses to Bring Asthma Care Into the Inner-City Schools Status COMPLETED Phase NA
NCT02734446 To Evaluate the Efficacy of Supplementation With L. Reuteri + Vit. D3 in Asthmatic Children Status COMPLETED Phase PHASE3
NCT02730351 Crossover Study Comparing Fluticasone Furoate (FF)/Vilanterol (VI) Once Daily Versus Fluticasone Propionate (FP) Twice Daily in Subjects With Asthma and Exercise-Induced Bronchoconstriction (EIB) Status COMPLETED Phase PHASE4
NCT02725242 Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down Asthma Status COMPLETED Phase PHASE3
NCT02725008 Trial of One Versus Two Doses of Dexamethasone for Pediatric Asthma Exacerbation Status COMPLETED Phase PHASE3
NCT02720081 Study of MK-1029 in Participants With Persistent Asthma That Cannot Be Controlled With Montelukast (MK-1029-015) Status COMPLETED Phase PHASE2